• Admin

New Covid treatments now available on Guam


By Pacific Island Times News Staff


Four Covid-19 treatments that have been approved by the Food and Drug Administration for use an Emergency Use Authorization are now available on Guam beginning Feb. 17, the government announced today.


Sotrovimab is for the treatment of mild-to-moderate Covid-19 in adults and pediatric patients (12 years of age and older weighing at least 88 lbs) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe Covid-19, including hospitalization or death.


Paxlovid by Pfizer is an oral antiviral (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for treatment of mild-to-moderate Covid-19 in adults and pediatric patients (12 years of age and older weighing at least 88 lbs) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe Covid-19, including hospitalization or death.


Molnupiravir by Merck is for the treatment of mild-to-moderate Covid-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe Covid-19, including hospitalization or death, and for whom alternative Covid-19 treatment options authorized by the FDA are not accessible or clinically appropriate. Molnupiravir is available by prescription only and should be initiated as soon as possible after diagnosis of Covid-19 and within five days of symptom onset.


Evusheld by AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab and administered together) is for the pre-exposure prophylaxis or prevention of Covid-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 88 lbs.


ADVERTISEMENT


Today, the Department of Public Health and Social Services reported 394 new cases of Covid-19 from 1,185 specimens analyzed on Feb. 16. Of this total, 72 cases were reported today are through the Department of Defense. To date, there have been a total of 41,780 officially reported cases, 315 deaths, 5,446 cases in active isolation, and 36,019 not in active isolation.



Subscribe to

our digital

monthly edition